NEW YORK, Aug. 24 – Shareholders of UK-based Gemini Genomics and US-based Sequenom have approved the firms’ plans to merge, the companies said on Thursday.

The combined company, which will retain the name Sequenom, must still obtain approval from the High Court of Justice in England and Wales. The companies anticipate the deal to close at the end of September.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.